
Dr. Martin Engel is an experienced strategic lifescience partnership manager with strong expertise in neuropharmacology. In his role as Medical & Scientific Partnerships Lead at Neurizon, he drives global engagement with pharmaceutical partners, supporting scientific due diligence, shaping program positioning, and providing input to clinical and pre-clinical development planning aligned with partner expectations. Martin brings a proven ability to work across clinical, pre-clinical, and commercial teams, with a track record of building trusted external relationships across US, EU and APAC, and representing organisations in scientific and industry forums; he holds a PhD in neuropharmacology and has published widely on treatment development across central nervous system disorders.